Peptonic Medical closes SEK 6 mln rights issue to group of new investors

Friday, August 05, 2016

Peptonic Medical AB Said on Wednesday had completed a rights issue of 6 million Swedish crowns ($701,582.07) (before transaction costs equivalent to 10 pct of the total rights issue amount), to a selected group of new investors.

A total of 1,428,572 shares were issued at a subscription price of 4.20 crowns per share.

Proceeds from this rights issue will be used to start the preparations of the clinical phase 3 programme as well as to start preparing and conducting a pilot study on a new medical indication that is protected by patents proprietary to the Company.

The number of issued shares in the Company will increase by 1,428,572 to 20,602,984, corresponding to a share capital of 2,060,298.40 crowns as a result of this rights issue.


Source :